Slide 1: Q2 FY25 Quarterly Webinar Presentation
ASX Announcement – 3 February 2025 Visionflex Group Limited (ASX:VFX) Q2 FY25 Quarterly Webinar Presentation Visionflex Group Ltd (ASX:VFX) (“Visionflex Group” or “The Company”), a leader in virtual diagnostic healthcare technology solutions, is pleased to advise that CEO Joshua Mundey will today de
Slide 2: Q2 FY25 Results
ASX:VFX For personal use only Q2 FY25 Results FEBRUARY 2025 2Q FY25 RESULTS / FEBRUARY 25 / 1
Slide 3: The Visionflex mission
The Visionflex mission Empowering health practitioners globally with cutting For personal use only edge technologies to elevate patient outcomes. PROPRIETARY PROPRIETARY HARDWARE SOFTWARE THIRD PARTY HARDWARE Visionflex proprietary hardware and software connect a range of third-party medical devices
Slide 4: Hardware
Hardware Visionflex hardware enables health practitioners to virtually conduct medical examinations with confidence and serves as a foundational step for establishing long term software subscriptions. For personal use only PERIPHERALS + SOFTWARE DEVICE + PERIPHERALS + SOFTWARE MEDICAL CART + PERIPHE
Slide 5: Proprietary Software (Virtual Care Platform)
Proprietary Software (Virtual Care Platform) A virtual healthcare platform allowing practitioners to virtually examine, diagnose, monitor, and treat patients. For personal use only Perform collaborative, clinical, evidence-based consultations between clinicians A user-friendly video conferencing pla
Slide 6: Revenue Model
Revenue Model For personal use only Offering Core HARDWARE SOFTWARE Key Product / Services Revenue RECURRING REVENUE Streams UPFRONT / ONE-OFF $5k – $30k per unit depending on solution ~$5k per annum for annual software license margin 60-65% GP margin 90-95% GP margin GP Revenue Repeat Each new soft
Slide 7: Q2 FY25 Highlights
Q2 FY25 Highlights For personal use only $0.9m Revenue $1.6M ARR* $0.8M Cash Receipts ~37% from recurring software & support Up 8% from Q1 FY25 and 114% on the pcp Up 3% on Q1 FY25 and down 60% on the pcp 12% down on Q1 FY25 and 47% on the pcp ($0.5M) Operating Cash Several Key Contracts $2.4M Cash
Slide 8: Q2 FY25 Financial Trends
Q2 FY25 Financial Trends REVENUE ($m) ARR ($m) For personal use only 2.5 2.0 1.6 2.0 1.6 1.5 0.2 0.2 1.3 1.5 0.4 1.2 1.1 0.1 1.0 0.8 0.7 1.8 1.8 0.4 0.3 1.2 1.3 0.4 0.5 0.4 0.6 0.6 - 0.0 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Non-recurring Revenue Recurring Revenue (
Slide 9: Q2 FY25 Financial Trends
Q2 FY25 Financial Trends C A S H R E C E I PTS ( $ m ) NET OPERATING CASH FLOW ($m) For personal use only 5.0 1.0 3.9 0.5 0.4 4.0 - 3.0 (0.2) (0.5) 2.0 2.1 (0.5) 2.0 1.8 (0.6) (1.0) (1.0) 1.0 0.8 0.8 (1.5) (1.6) - (2.0) Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Receipts
Slide 10: Business Update
Business Update Key contracts secured during Q2 FY25 included: For personal use only 1 Spark Health (NZ), subsidiary of one of NZ’s largest Telco companies: • Reseller agreement to deliver virtual care solutions in NZ. • First contract secured in November 2024 worth approx. $0.1m which was deployed
Slide 11: Outlook – H2 FY25 & Beyond
Outlook – H2 FY25 & Beyond For personal use only 1 Strategic plan to deliver profitable growth: 2 Transitioning to recurring revenue via SaaS : • Targeting to be run-rate EBITDA positive in Q4 FY25. • Transition to SaaS pricing delivering growth in annual • Qualified pipeline >$25m. recurring revenu
Slide 12: Important notices
Important notices For personal use only This results presentation (Presentation) has been prepared by Visionflex Group Limited ACN 138 897 533 (ASX:VFX) (Company) and is dated 3 February 2025. A number of figures, amounts, percentages, estimates, calculations of values and fractions in this Presenta
Slide 13: Visionflex Group Limited
For personal use only Visionflex Group Limited Unit 1, 8 Prosperity Parade, Warriewood NSW 2102 VISIONFLEX.COM.AU Joshua Mundey CHIEF EXECUTIVE OFFICER E: jmundey@visionflex.com 2Q FY25 RESULTS / FEBRUARY 25 / 1 12 2